{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:27:38Z","timestamp":1794652058800,"version":"4.9.1"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"American Heart Association Career Development Grant"},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Austrian Science Fund (FWF) for excellence cluster"},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Alberta Chair in Sex and Gender"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Sex Differ"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cardiovascular\u2013kidney\u2013metabolic (CKM) syndrome represents a continuum of interrelated adiposity, insulin resistance, cardiovascular disease, kidney dysfunction, and metabolic disturbances that evolve across the lifespan. Emerging evidence demonstrates that both biological sex and sociocultural gender significantly shape CKM risk, progression, and clinical expression. CKM syndrome pathogenesis reflects complex multisystem interactions involving adipose tissue dysfunction, neurohormonal activation, inflammatory signaling, and vascular impairment, all of which exhibit important sex-specific patterns. This review examines CKM syndrome from a sex- and gender-informed perspective, highlighting how endogenous and exogenous sex hormones, reproductive transitions, pregnancy-related complications, and dietary exposures shape the long-term CKM syndrome risk. Particular attention is given to the roles of estrogen and testosterone in modulating adipose biology, vascular function, and metabolic regulation. Polycystic ovary syndrome is discussed as a model of androgen excess and multisystem metabolic vulnerability that accelerates CKM features. Finally, we address brain vulnerability within CKM syndrome, emphasizing shared inflammatory, vascular, and neuroendocrine mechanisms linking metabolic dysfunction to cognitive decline and neuropsychiatric disorders. Recognizing these interconnected and sex-specific influences is critical for advancing precision prevention and treatment strategies across the CKM syndrome spectrum.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1186\/s13293-026-00878-w","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T22:29:23Z","timestamp":1778538563000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Challenges and knowledge gaps in sex differences in cardio\u2013kidney\u2013metabolic syndrome across the lifespan"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7031-2523","authenticated-orcid":false,"given":"Aline M. A.","family":"de Souza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3520-4105","authenticated-orcid":false,"given":"Alexandra","family":"Kautzky-Willer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7268-9690","authenticated-orcid":false,"given":"Damian G.","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7295-1871","authenticated-orcid":false,"given":"Licy L.","family":"Yanes Cardozo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3000-2229","authenticated-orcid":false,"given":"Sofia B.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4421-0686","authenticated-orcid":false,"given":"Samar","family":"Rezq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"issue":"20","key":"878_CR1","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Neeland IJ, Tuttle KR, Chow SL, Mathew RO, Khan SS, et al. A synopsis of the evidence for the science and clinical management of Cardiovascular-Kidney-Metabolic (CKM) syndrome: a scientific statement from the American Heart Association. Circulation. 2023;148(20):1636\u201364. https:\/\/doi.org\/10.1161\/CIR.0000000000001186.","journal-title":"Circulation"},{"issue":"1","key":"878_CR2","doi-asserted-by":"publisher","first-page":"C1","DOI":"10.1152\/ajpcell.00499.2025","volume":"330","author":"S Gunnarsson","year":"2026","unstructured":"Gunnarsson S, Vito O, Unwin RJ. Cardiovascular-kidney-metabolic syndrome: prevalence, risks, disease trajectories, and early-stage management. Am J Physiol Cell Physiol. 2026;330(1):C1\u20138. https:\/\/doi.org\/10.1152\/ajpcell.00499.2025.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"11","key":"878_CR3","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.45309","volume":"7","author":"R Zhu","year":"2024","unstructured":"Zhu R, Wang R, He J, Wang L, Chen H, Niu X, et al. Prevalence of cardiovascular-kidney-metabolic syndrome stages by social determinants of health. JAMA Netw Open. 2024;7(11):e2445309. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.45309.","journal-title":"JAMA Netw Open"},{"issue":"6","key":"878_CR4","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1007\/s00125-023-05891-x","volume":"66","author":"A Kautzky-Willer","year":"2023","unstructured":"Kautzky-Willer A, Leutner M, Harreiter J. Sex differences in type 2 diabetes. Diabetologia. 2023;66(6):986\u20131002. https:\/\/doi.org\/10.1007\/s00125-023-05891-x.","journal-title":"Diabetologia"},{"key":"878_CR5","doi-asserted-by":"publisher","first-page":"10487","DOI":"10.1016\/S0140-6736(25)00488-X","volume":"405","author":"S Hawkes","year":"2025","unstructured":"Hawkes S, Sy EA, Barker G, Baum FE, Buse K, Chang AY, et al. Achieving gender justice for global health equity: the Lancet Commission on gender and global health. Lancet. 2025;405:10487. https:\/\/doi.org\/10.1016\/S0140-6736(25)00488-X.","journal-title":"Lancet"},{"issue":"12","key":"878_CR6","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1002\/oby.24153","volume":"32","author":"J Harreiter","year":"2024","unstructured":"Harreiter J, Just I, Weber M, Klepochova R, Bastian M, Winhofer Y, et al. Sex differences in ectopic lipid deposits and cardiac function across a wide range of glycemic control: a secondary analysis. Obesity. 2024;32(12):2299\u2013309. https:\/\/doi.org\/10.1002\/oby.24153.","journal-title":"Obesity"},{"issue":"1","key":"878_CR7","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1161\/ATVBAHA.124.321629","volume":"45","author":"H Ji","year":"2025","unstructured":"Ji H, Sabanayagam C, Matsushita K, Cheng CY, Rim TH, Sheng B, et al. Sex differences in Cardiovascular-Kidney-Metabolic syndrome: 30-year US trends and mortality risks-brief report. Arterioscler Thromb Vasc Biol. 2025;45(1):157\u201361. https:\/\/doi.org\/10.1161\/ATVBAHA.124.321629.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"878_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13154354","author":"M Guldan","year":"2024","unstructured":"Guldan M, Unlu S, Abdel-Rahman SM, Ozbek L, Gaipov A, Covic A, et al. Understanding the role of sex hormones in cardiovascular kidney metabolic syndrome: toward personalized therapeutic approaches. J Clin Med. 2024. https:\/\/doi.org\/10.3390\/jcm13154354.","journal-title":"J Clin Med"},{"issue":"3","key":"878_CR9","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.kint.2025.02.021","volume":"108","author":"GB Piccoli","year":"2025","unstructured":"Piccoli GB, Ahmed SB, Fakhouri F, Garovic VD, Hladunewich MA, Jesudason S, et al. Women and kidney health: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference. Kidney Int. 2025;108(3):355\u201379. https:\/\/doi.org\/10.1016\/j.kint.2025.02.021.","journal-title":"Kidney Int"},{"key":"878_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.mce.2014.11.029","volume":"402","author":"BF Palmer","year":"2015","unstructured":"Palmer BF, Clegg DJ. The sexual dimorphism of obesity. Mol Cell Endocrinol. 2015;402:113\u20139. https:\/\/doi.org\/10.1016\/j.mce.2014.11.029.","journal-title":"Mol Cell Endocrinol"},{"issue":"11","key":"878_CR11","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.019968","volume":"10","author":"AA Kammerlander","year":"2021","unstructured":"Kammerlander AA, Lyass A, Mahoney TF, Massaro JM, Long MT, Vasan RS, et al. Sex differences in the associations of visceral adipose tissue and cardiometabolic and cardiovascular disease risk: the Framingham Heart Study. J Am Heart Assoc. 2021;10(11):e019968. https:\/\/doi.org\/10.1161\/JAHA.120.019968.","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"878_CR12","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","volume":"13","author":"F Rubino","year":"2025","unstructured":"Rubino F, Cummings DE, Eckel RH, Cohen RV, Wilding JPH, Brown WA, et al. Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol. 2025;13(3):221\u201362. https:\/\/doi.org\/10.1016\/S2213-8587(24)00316-4.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"878_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2026.156573","volume":"179","author":"L Liu","year":"2026","unstructured":"Liu L, Cai AP, Wu KCH, Xu AM, Lip GYH, Cheng Y, et al. Sex differences in cardiovascular-kidney-metabolic syndrome and new onset cardiovascular outcomes. Metabolism. 2026;156573. https:\/\/doi.org\/10.1016\/j.metabol.2026.156573.","journal-title":"Metabolism"},{"issue":"1","key":"878_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41574-020-00431-8","volume":"17","author":"GH Goossens","year":"2021","unstructured":"Goossens GH, Jocken JWE, Blaak EE. Sexual dimorphism in cardiometabolic health: the role of adipose tissue, muscle and liver. Nat Rev Endocrinol. 2021;17(1):47\u201366. https:\/\/doi.org\/10.1038\/s41574-020-00431-8.","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"878_CR15","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.molmet.2013.05.006","volume":"2","author":"KE Davis","year":"2013","unstructured":"Davis KE, M DN, Sun K, W MS, J DB, J AZ, et al. The sexually dimorphic role of adipose and adipocyte estrogen receptors in modulating adipose tissue expansion, inflammation, and fibrosis. Mol Metab. 2013;2(3):227\u201342. https:\/\/doi.org\/10.1016\/j.molmet.2013.05.006.","journal-title":"Mol Metab"},{"issue":"1","key":"878_CR16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/dom.14206","volume":"23","author":"P Dandona","year":"2021","unstructured":"Dandona P, Dhindsa S, Ghanim H, Saad F. Mechanisms underlying the metabolic actions of testosterone in humans: a narrative review. Diabetes Obes Metab. 2021;23(1):18\u201328. https:\/\/doi.org\/10.1111\/dom.14206.","journal-title":"Diabetes Obes Metab"},{"issue":"10","key":"878_CR17","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1210\/clinem\/dgad193","volume":"108","author":"BC Cossins","year":"2023","unstructured":"Cossins BC, van den Munckhof I, Rutten JHW, van der Graaf M, Stienstra R, Joosten LAB, et al. Sex-specific association between adipose tissue inflammation and vascular and metabolic complications of obesity. J Clin Endocrinol Metab. 2023;108(10):2537\u201349. https:\/\/doi.org\/10.1210\/clinem\/dgad193.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"878_CR18","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1210\/clinem\/dgab325","volume":"106","author":"X Li","year":"2021","unstructured":"Li X, Liu J, Zhou B, Li Y, Wu Z, Meng H, et al. Sex differences in the effect of testosterone on adipose tissue insulin resistance from overweight to obese adults. J Clin Endocrinol Metab. 2021;106(8):2252\u201363. https:\/\/doi.org\/10.1210\/clinem\/dgab325.","journal-title":"J Clin Endocrinol Metab"},{"key":"878_CR19","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqaf173","author":"AM Abdelhameed","year":"2025","unstructured":"Abdelhameed AM, Eissa MA, Thompson K, Edwards KS, Hoang NH, Rezq S, et al. Adiponectin receptor agonist AdipoRon ameliorates the metabolic complications in a hyperandrogenic rat model of PCOS. Endocrinology. 2025. https:\/\/doi.org\/10.1210\/endocr\/bqaf173.","journal-title":"Endocrinology"},{"key":"878_CR20","first-page":"7767","volume":"29","author":"The 2022 hormone therapy position statement of The North American Menopause Society","year":"2022","unstructured":"The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29:7767\u201394.","journal-title":"Menopause"},{"key":"878_CR21","unstructured":"United Nations Department of Economic and Social Affairs, Population Division. (2022). World Family Planning 2022: Meeting the changing needs for family planning: Contraceptive use by age and method. UN DESA\/POP\/2022\/TR\/NO. 4. https:\/\/www.un.org\/development\/desa\/pd\/sites\/www.un.org.development.desa.pd\/files\/files\/documents\/2023\/Feb\/undesa_pd_2022_world-family-planning.pdf"},{"issue":"Suppl 1","key":"878_CR22","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1080\/26895269.2022.2100644","volume":"23","author":"E Coleman","year":"2022","unstructured":"Coleman E, Radix AE, Bouman WP, Brown GR, de Vries ALC, Deutsch MB, et al. Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. Int J Transgend Health. 2022;23(Suppl 1):S1\u2013259. https:\/\/doi.org\/10.1080\/26895269.2022.2100644.","journal-title":"Int J Transgend Health"},{"issue":"8","key":"878_CR23","doi-asserted-by":"publisher","first-page":"548","DOI":"10.5694\/mja13.10111","volume":"199","author":"DJ Handelsman","year":"2013","unstructured":"Handelsman DJ. Global trends in testosterone prescribing, 2000\u20132011: expanding the spectrum of prescription drug misuse. Med J Aust. 2013;199(8):548\u201351. https:\/\/doi.org\/10.5694\/mja13.10111.","journal-title":"Med J Aust"},{"issue":"1","key":"878_CR24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.eprac.2023.09.012","volume":"30","author":"A Sood","year":"2024","unstructured":"Sood A, Hosseinpour A, Sood A, Avula S, Durrani J, Bhatia V, et al. Cardiovascular outcomes of hypogonadal men receiving testosterone replacement therapy: a meta-analysis of randomized controlled trials. Endocr Pract. 2024;30(1):2\u201310. https:\/\/doi.org\/10.1016\/j.eprac.2023.09.012.","journal-title":"Endocr Pract"},{"issue":"1","key":"878_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-023-02788-0","volume":"24","author":"Y Gu","year":"2024","unstructured":"Gu Y, Han F, Xue M, Wang M, Huang Y. The benefits and risks of menopause hormone therapy for the cardiovascular system in postmenopausal women: a systematic review and meta-analysis. BMC Womens Health. 2024;24(1):60. https:\/\/doi.org\/10.1186\/s12905-023-02788-0.","journal-title":"BMC Womens Health"},{"issue":"6","key":"878_CR26","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1080\/10826084.2025.2460986","volume":"60","author":"L Mingxing","year":"2025","unstructured":"Mingxing L, Yanfei Y. Adverse effects of anabolic androgenic steroid abuse in athletes and physically active individuals: a systematic review and meta-analysis. Subst Use Misuse. 2025;60(6):873\u201387. https:\/\/doi.org\/10.1080\/10826084.2025.2460986.","journal-title":"Subst Use Misuse"},{"issue":"9","key":"878_CR27","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.15267","volume":"10","author":"CZ Kalenga","year":"2022","unstructured":"Kalenga CZ, Dumanski SM, Metcalfe A, Robert M, Nerenberg KA, MacRae JM, et al. The effect of non-oral hormonal contraceptives on hypertension and blood pressure: a systematic review and meta-analysis. Physiol Rep. 2022;10(9):e15267. https:\/\/doi.org\/10.14814\/phy2.15267.","journal-title":"Physiol Rep"},{"issue":"5","key":"878_CR28","doi-asserted-by":"publisher","first-page":"H861","DOI":"10.1152\/ajpheart.00299.2022","volume":"323","author":"K Turino Miranda","year":"2022","unstructured":"Turino Miranda K, Kalenga CZ, Saad N, Dumanski SM, Collister D, Rytz CL, et al. Gender-affirming estrogen therapy route of administration and cardiovascular risk: a systematic review and narrative synthesis. Am J Physiol Heart Circ Physiol. 2022;323(5):H861\u20138. https:\/\/doi.org\/10.1152\/ajpheart.00299.2022.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"878_CR29","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/GME.0000000000002359","volume":"31","author":"L Ferreira Campos","year":"2024","unstructured":"Ferreira Campos L, de Andrade Costa G, Domingues Feitosa M, Ferreira Felix I, Gabrielli L, MDC CA, et al. Effect of hormone therapy on blood pressure and hypertension in postmenopausal women: a systematic review and meta-analysis. Menopause. 2024;31:6. https:\/\/doi.org\/10.1097\/GME.0000000000002359.","journal-title":"Menopause"},{"key":"878_CR30","doi-asserted-by":"publisher","unstructured":"Kortsmit K, Nguyen AT, Curtis KM, Burgner A, Folger S, Tepper NK, et al. Safety and effectiveness of contraception among women with chronic kidney disease: A systematic review. Contraception. 2025;111207. https:\/\/doi.org\/10.1016\/j.contraception.2025.111207.","DOI":"10.1016\/j.contraception.2025.111207"},{"key":"878_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252212221","author":"N Mlynarz","year":"2024","unstructured":"Mlynarz N, Miedziaszczyk M, Wieckowska B, Szalek E, Lacka K. Effects of testosterone replacement therapy on metabolic syndrome in male patients-systematic review. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms252212221.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"878_CR32","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/S2213-8587(19)30189-5","volume":"7","author":"RM Islam","year":"2019","unstructured":"Islam RM, Bell RJ, Green S, Page MJ, Davis SR. Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data. Lancet Diabetes Endocrinol. 2019;7(10):754\u201366. https:\/\/doi.org\/10.1016\/S2213-8587(19)30189-5.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"878_CR33","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1097\/GME.0000000000000657","volume":"23","author":"S Ramesh","year":"2016","unstructured":"Ramesh S, Mann MC, Holroyd-Leduc JM, Wilton SB, James MT, Seely EW, et al. Hormone therapy and clinical and surrogate cardiovascular endpoints in women with chronic kidney disease: a systematic review and meta-analysis. Menopause. 2016;23(9):1028\u201337. https:\/\/doi.org\/10.1097\/GME.0000000000000657.","journal-title":"Menopause"},{"key":"878_CR34","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaf573","author":"S van Eeghen","year":"2025","unstructured":"van Eeghen S, Pyle L, Narongkiatikhun P, Choi YJ, Vosters T, van Valkengoed I, et al. Insulin sensitivity and associated plasma proteomics during sex hormone therapy. J Clin Endocrinol Metab. 2025. https:\/\/doi.org\/10.1210\/clinem\/dgaf573.","journal-title":"J Clin Endocrinol Metab"},{"key":"878_CR35","doi-asserted-by":"publisher","first-page":"6673","DOI":"10.1080\/13697137.2025.2509844","volume":"28","author":"T Li","year":"2025","unstructured":"Li T, Jiang NS, Kaskey J, Schnatz PF, Nudy M. Hormone therapy and insulin resistance in non-diabetic postmenopausal women: a systematic review and meta-analysis. Climacteric. 2025;28:6673\u201381. https:\/\/doi.org\/10.1080\/13697137.2025.2509844.","journal-title":"Climacteric"},{"key":"878_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/biology15020173","author":"H Salazar-Gonzalez","year":"2026","unstructured":"Salazar-Gonzalez H, Gutierrez-Mercado YK, Echavarria R. The influence of sex and hormones on organelle stress in kidney injury: insights from preclinical models. Biology (Basel). 2026. https:\/\/doi.org\/10.3390\/biology15020173.","journal-title":"Biology (Basel)"},{"issue":"2","key":"878_CR37","doi-asserted-by":"publisher","first-page":"301","DOI":"10.2215\/CJN.0000000642","volume":"20","author":"SA van Eeghen","year":"2024","unstructured":"van Eeghen SA, Nokoff NJ, Vosters TG, Oosterom-Eijmael MJP, Cherney DZI, van Valkengoed IGM, et al. Unraveling sex differences in kidney health and CKD: a review of the effect of sex hormones. Clin J Am Soc Nephrol. 2024;20(2):301\u201310. https:\/\/doi.org\/10.2215\/CJN.0000000642.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"878_CR38","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.2337\/diacare.28.8.1988","volume":"28","author":"SB Ahmed","year":"2005","unstructured":"Ahmed SB, Hovind P, Parving HH, Rossing P, Price DA, Laffel LM, et al. Oral contraceptives, angiotensin-dependent renal vasoconstriction, and risk of diabetic nephropathy. Diabetes Care. 2005;28(8):1988\u201394. https:\/\/doi.org\/10.2337\/diacare.28.8.1988.","journal-title":"Diabetes Care"},{"key":"878_CR39","doi-asserted-by":"publisher","first-page":"7645","DOI":"10.1056\/NEJMsb022365","volume":"348","author":"F Grodstein","year":"2003","unstructured":"Grodstein F, Clarkson TB, Manson JE. Understanding the divergent data on postmenopausal hormone therapy. N Engl J Med. 2003;348:7645\u201350. https:\/\/doi.org\/10.1056\/NEJMsb022365.","journal-title":"N Engl J Med"},{"issue":"9","key":"878_CR40","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2024.3128","volume":"5","author":"L Yang","year":"2024","unstructured":"Yang L, Toriola AT. Menopausal hormone therapy use among postmenopausal women. JAMA Health Forum. 2024;5(9):e243128. https:\/\/doi.org\/10.1001\/jamahealthforum.2024.3128.","journal-title":"JAMA Health Forum"},{"issue":"24","key":"878_CR41","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1161\/CIR.0000000000001191","volume":"148","author":"SS Khan","year":"2023","unstructured":"Khan SS, Coresh J, Pencina MJ, Ndumele CE, Rangaswami J, Chow SL, et al. Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: a scientific statement from the American Heart Association. Circulation. 2023;148(24):1982\u20132004. https:\/\/doi.org\/10.1161\/CIR.0000000000001191.","journal-title":"Circulation"},{"key":"878_CR42","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ahj.2022.01.007","volume":"247","author":"R Hassan","year":"2022","unstructured":"Hassan R, Riehl-Tonn VJ, Dumanski SM, Lyons KJ, Ahmed SB. Female sex-specific and -predominant cardiovascular risk factors and heart failure practice guidelines. Am Heart J. 2022;247:63\u20137. https:\/\/doi.org\/10.1016\/j.ahj.2022.01.007.","journal-title":"Am Heart J"},{"key":"878_CR43","doi-asserted-by":"publisher","first-page":"9727","DOI":"10.1016\/j.eprac.2023.04.013","volume":"29","author":"J Buratto","year":"2023","unstructured":"Buratto J, Kirk B, Phu S, Vogrin S, Duque G. Safety and efficacy of testosterone therapy on musculoskeletal health and clinical outcomes in men: a systematic review and meta-analysis of randomized placebo-controlled trials. Endocr Pract. 2023;29:9727\u201334. https:\/\/doi.org\/10.1016\/j.eprac.2023.04.013.","journal-title":"Endocr Pract"},{"issue":"2","key":"878_CR44","doi-asserted-by":"publisher","first-page":"e455","DOI":"10.1210\/clinem\/dgad414","volume":"109","author":"AS Cheung","year":"2024","unstructured":"Cheung AS, Zwickl S, Miller K, Nolan BJ, Wong AFQ, Jones P, et al. The impact of gender-affirming hormone therapy on physical performance. J Clin Endocrinol Metab. 2024;109(2):e455\u201365. https:\/\/doi.org\/10.1210\/clinem\/dgad414.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"878_CR45","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.10154","volume":"2","author":"AA Javed","year":"2019","unstructured":"Javed AA, Mayhew AJ, Shea AK, Raina P. Association between hormone therapy and muscle mass in postmenopausal women: a systematic review and meta-analysis. JAMA Netw Open. 2019;2(8):e1910154. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.10154.","journal-title":"JAMA Netw Open"},{"key":"878_CR46","doi-asserted-by":"publisher","DOI":"10.1172\/JCI190850","author":"SA van Eeghen","year":"2025","unstructured":"van Eeghen SA, Pyle L, Narongkiatikhun P, Choi YJ, Obeid W, Parikh CR, et al. Unveiling mechanisms underlying kidney function changes during sex hormone therapy. J Clin Invest. 2025. https:\/\/doi.org\/10.1172\/JCI190850.","journal-title":"J Clin Invest"},{"issue":"9","key":"878_CR47","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.2215\/CJN.01890222","volume":"17","author":"E Krupka","year":"2022","unstructured":"Krupka E, Curtis S, Ferguson T, Whitlock R, Askin N, Millar AC, et al. The effect of gender-affirming hormone therapy on measures of kidney function: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2022;17(9):1305\u201315. https:\/\/doi.org\/10.2215\/CJN.01890222.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"878_CR48","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.kint.2024.06.030","volume":"106","author":"K Turino Miranda","year":"2024","unstructured":"Turino Miranda K, Dumanski SM, Saad N, Inker LA, White CA, Delanaye P, et al. Glomerular filtration rate estimation in transgender and gender-diverse adults using gender-affirming hormone therapy: an exploratory cross-sectional study. Kidney Int. 2024;106(4):753\u20136. https:\/\/doi.org\/10.1016\/j.kint.2024.06.030.","journal-title":"Kidney Int"},{"key":"878_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s13293-026-00838-4","author":"RL Cunningham","year":"2026","unstructured":"Cunningham RL, Galea LAM, Goulmamine S, Kararigas G, Schubert KG, Zuloaga KL, et al. Advancing evidence-based regulation: Organization for the Study of Sex Differences and Society for Women\u2019s Health Research support FDA action on menopausal hormone therapy and encourage broader sex-informed drug label updates. Biol Sex Differ. 2026. https:\/\/doi.org\/10.1186\/s13293-026-00838-4.","journal-title":"Biol Sex Differ"},{"issue":"2","key":"878_CR50","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa2215025","volume":"389","author":"AM Lincoff","year":"2023","unstructured":"Lincoff AM, Bhasin S, Flevaris P, Mitchell LM, Basaria S, Boden WE, et al. Cardiovascular safety of testosterone-replacement therapy. N Engl J Med. 2023;389(2):107\u201317. https:\/\/doi.org\/10.1056\/NEJMoa2215025.","journal-title":"N Engl J Med"},{"key":"878_CR51","unstructured":"FDA issues class-wide labeling changes for testosterone products. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-issues-class-wide-labeling-changes-testosterone-products (2025)."},{"issue":"3","key":"878_CR52","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.0427","volume":"7","author":"JMT Colombijn","year":"2024","unstructured":"Colombijn JMT, Idema DL, van Beem S, Blokland AM, van der Braak K, Handoko ML, et al. Representation of patients with chronic kidney disease in clinical trials of cardiovascular disease medications: a systematic review. JAMA Netw Open. 2024;7(3):e240427. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.0427.","journal-title":"JAMA Netw Open"},{"key":"878_CR53","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.preghy.2022.01.011","volume":"28","author":"CRV Leal","year":"2022","unstructured":"Leal CRV, Costa LB, Ferreira GC, Ferreira AM, Reis FM, Simoes ESAC. Renin-angiotensin system in normal pregnancy and in preeclampsia: a comprehensive review. Pregnancy Hypertens. 2022;28:15\u201320. https:\/\/doi.org\/10.1016\/j.preghy.2022.01.011.","journal-title":"Pregnancy Hypertens"},{"issue":"2","key":"878_CR54","doi-asserted-by":"publisher","DOI":"10.1111\/micc.12464","volume":"26","author":"M Jelinic","year":"2019","unstructured":"Jelinic M, Marshall SA, Leo CH, Parry LJ, Tare M. From pregnancy to cardiovascular disease: lessons from relaxin-deficient animals to understand relaxin actions in the vascular system. Microcirculation. 2019;26(2):e12464. https:\/\/doi.org\/10.1111\/micc.12464.","journal-title":"Microcirculation"},{"issue":"2","key":"878_CR55","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1161\/01.HYP.0000200042.64517.19","volume":"47","author":"SP Salas","year":"2006","unstructured":"Salas SP, Marshall G, Gutierrez BL, Rosso P. Time course of maternal plasma volume and hormonal changes in women with preeclampsia or fetal growth restriction. Hypertension. 2006;47(2):203\u20138. https:\/\/doi.org\/10.1161\/01.HYP.0000200042.64517.19.","journal-title":"Hypertension"},{"issue":"6","key":"878_CR56","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1053\/j.ackd.2020.07.006","volume":"27","author":"K Beers","year":"2020","unstructured":"Beers K, Patel N. Kidney physiology in pregnancy. Adv Chronic Kidney Dis. 2020;27(6):449\u201354. https:\/\/doi.org\/10.1053\/j.ackd.2020.07.006.","journal-title":"Adv Chronic Kidney Dis"},{"key":"878_CR57","doi-asserted-by":"publisher","first-page":"7438","DOI":"10.1016\/j.jsgi.2004.05.002","volume":"11","author":"KP Conrad","year":"2004","unstructured":"Conrad KP. Mechanisms of renal vasodilation and hyperfiltration during pregnancy. J Soc Gynecol Investig. 2004;11:7438\u201348. https:\/\/doi.org\/10.1016\/j.jsgi.2004.05.002.","journal-title":"J Soc Gynecol Investig"},{"issue":"3","key":"878_CR58","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1053\/j.semperi.2009.02.010","volume":"33","author":"L Duley","year":"2009","unstructured":"Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009;33(3):130\u20137. https:\/\/doi.org\/10.1053\/j.semperi.2009.02.010.","journal-title":"Semin Perinatol"},{"issue":"12","key":"878_CR59","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/s41574-022-00734-y","volume":"18","author":"L Jiang","year":"2022","unstructured":"Jiang L, Tang K, Magee LA, von Dadelszen P, Ekeroma A, Li X, et al. A global view of hypertensive disorders and diabetes mellitus during pregnancy. Nat Rev Endocrinol. 2022;18(12):760\u201375. https:\/\/doi.org\/10.1038\/s41574-022-00734-y.","journal-title":"Nat Rev Endocrinol"},{"key":"878_CR60","unstructured":"UNICEF. The State of Food Security and Nutrition in the World. 2025. https:\/\/data.unicef.org\/resources\/sofi-2025\/ (2026). Accessed February, 24, 2026 2026."},{"key":"878_CR61","doi-asserted-by":"publisher","first-page":"121692","DOI":"10.1161\/CIRCRESAHA.123.322065","volume":"132","author":"EJ Brandt","year":"2023","unstructured":"Brandt EJ, Mozaffarian D, Leung CW, Berkowitz SA, Murthy VL. Diet and Food and Nutrition Insecurity and Cardiometabolic Disease. Circ Res. 2023;132:121692\u2013706. https:\/\/doi.org\/10.1161\/CIRCRESAHA.123.322065.","journal-title":"Circ Res"},{"key":"878_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/nu14142881","author":"F Yao","year":"2022","unstructured":"Yao F, Zhao L, Yang Y, Piao W, Fang H, Ju L, et al. Association between early life famine exposure and metabolic syndrome in adulthood. Nutrients. 2022. https:\/\/doi.org\/10.3390\/nu14142881.","journal-title":"Nutrients"},{"issue":"7","key":"878_CR63","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.014175","volume":"9","author":"R Du","year":"2020","unstructured":"Du R, Zheng R, Xu Y, Zhu Y, Yu X, Li M, et al. Early-life famine exposure and risk of cardiovascular diseases in later life: findings from the REACTION study. J Am Heart Assoc. 2020;9(7):e014175. https:\/\/doi.org\/10.1161\/JAHA.119.014175.","journal-title":"J Am Heart Assoc"},{"key":"878_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2020.109312","volume":"184","author":"S Lv","year":"2020","unstructured":"Lv S, Shen Z, Zhang H, Yu X, Chen J, Gu Y, et al. Association between exposure to the Chinese famine during early life and the risk of chronic kidney disease in adulthood. Environ Res. 2020;184:109312. https:\/\/doi.org\/10.1016\/j.envres.2020.109312.","journal-title":"Environ Res"},{"issue":"1","key":"878_CR65","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/epirev\/mxt006","volume":"36","author":"JW Rich-Edwards","year":"2014","unstructured":"Rich-Edwards JW, Fraser A, Lawlor DA, Catov JM. Pregnancy characteristics and women\u2019s future cardiovascular health: an underused opportunity to improve women\u2019s health? Epidemiol Rev. 2014;36(1):57\u201370. https:\/\/doi.org\/10.1093\/epirev\/mxt006.","journal-title":"Epidemiol Rev"},{"key":"878_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11206048","author":"S Slawek-Szmyt","year":"2022","unstructured":"Slawek-Szmyt S, Kawka-Paciorkowska K, Cieplucha A, Lesiak M, Ropacka-Lesiak M. Preeclampsia and fetal growth restriction as risk factors of future maternal cardiovascular disease-a review. J Clin Med. 2022. https:\/\/doi.org\/10.3390\/jcm11206048.","journal-title":"J Clin Med"},{"issue":"11","key":"878_CR67","doi-asserted-by":"publisher","DOI":"10.1111\/apha.70113","volume":"241","author":"AM Barrell","year":"2025","unstructured":"Barrell AM, Sferruzzi-Perri AN. The impact of preeclampsia and gestational diabetes on future maternal cardiometabolic health. Acta Physiol Oxf. 2025;241(11):e70113. https:\/\/doi.org\/10.1111\/apha.70113.","journal-title":"Acta Physiol Oxf"},{"key":"878_CR68","unstructured":"Goals TG. Accessed February 24, 2026. 3: Good health and well-being. https:\/\/globalgoals.org\/goals\/3-good-health-and-well-being\/. 2026."},{"key":"878_CR69","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1016\/j.jacc.2020.03.060","volume":"75","author":"L Cho","year":"2020","unstructured":"Cho L, Davis M, Elgendy I, Epps K, Lindley KJ, Mehta PK, et al. Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020;75:20:2602\u201318. https:\/\/doi.org\/10.1016\/j.jacc.2020.03.060.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"878_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-024-00511-3","volume":"10","author":"E Stener-Victorin","year":"2024","unstructured":"Stener-Victorin E, Teede H, Norman RJ, Legro R, Goodarzi MO, Dokras A, et al. Polycystic ovary syndrome. Nature reviews Disease primers. 2024;10(1):27. https:\/\/doi.org\/10.1038\/s41572-024-00511-3.","journal-title":"Nature reviews Disease primers"},{"issue":"14","key":"878_CR71","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1056\/NEJMc1610000","volume":"375","author":"JE Nestler","year":"2016","unstructured":"Nestler JE. Polycystic Ovary Syndrome. N Engl J Med. 2016;375(14):1398. https:\/\/doi.org\/10.1056\/NEJMc1610000.","journal-title":"N Engl J Med"},{"issue":"4","key":"878_CR72","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41574-024-01057-w","volume":"21","author":"N Helvaci","year":"2025","unstructured":"Helvaci N, Yildiz BO. Polycystic ovary syndrome as a metabolic disease. Nat Rev Endocrinol. 2025;21(4):230\u201344. https:\/\/doi.org\/10.1038\/s41574-024-01057-w.","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"878_CR73","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1152\/physiol.00030.2016","volume":"32","author":"LL Yanes Cardozo","year":"2017","unstructured":"Yanes Cardozo LL, Romero DG, Reckelhoff JF. Cardiometabolic features of polycystic ovary syndrome: role of androgens. Physiology (Bethesda). 2017;32(5):357\u201366. https:\/\/doi.org\/10.1152\/physiol.00030.2016.","journal-title":"Physiology (Bethesda)"},{"issue":"5","key":"878_CR74","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.fertnstert.2022.03.008","volume":"117","author":"K van der Ham","year":"2022","unstructured":"van der Ham K, Louwers YV, Laven JSE. Cardiometabolic biomarkers in women with polycystic ovary syndrome. Fertil Steril. 2022;117(5):887\u201396. https:\/\/doi.org\/10.1016\/j.fertnstert.2022.03.008.","journal-title":"Fertil Steril"},{"key":"878_CR75","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa674","author":"CB Newman","year":"2020","unstructured":"Newman CB, Blaha MJ, Boord JB, Cariou B, Chait A, Fein HG, et al. Lipid management in patients with endocrine disorders: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2020. https:\/\/doi.org\/10.1210\/clinem\/dgaa674.","journal-title":"J Clin Endocrinol Metab"},{"issue":"16","key":"878_CR76","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.033572","volume":"13","author":"CT Tay","year":"2024","unstructured":"Tay CT, Mousa A, Vyas A, Pattuwage L, Tehrani FR, Teede H. 2023 International Evidence-Based Polycystic Ovary Syndrome Guideline Update: insights from a systematic review and meta-analysis on elevated clinical cardiovascular disease in Polycystic Ovary Syndrome. J Am Heart Assoc. 2024;13(16):e033572. https:\/\/doi.org\/10.1161\/JAHA.123.033572.","journal-title":"J Am Heart Assoc"},{"key":"878_CR77","doi-asserted-by":"publisher","first-page":"e93369","DOI":"10.1210\/clinem\/dgab392","volume":"106","author":"TR Berni","year":"2021","unstructured":"Berni TR, Morgan CL, Rees DA. Women with polycystic ovary syndrome have an increased risk of major cardiovascular events: a population study. J Clin Endocrinol Metab. 2021;106:e93369-80. https:\/\/doi.org\/10.1210\/clinem\/dgab392.","journal-title":"J Clin Endocrinol Metab"},{"key":"878_CR78","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwaf351","author":"E Havers-Borgersen","year":"2025","unstructured":"Havers-Borgersen E, Ekelund C, Svendsen PF, Reinert MS, Vistisen H, Butt JH, et al. Polycystic ovarian syndrome and long-term risk of acute myocardial infarction and ischaemic stroke. Eur J Prev Cardiol. 2025. https:\/\/doi.org\/10.1093\/eurjpc\/zwaf351.","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"878_CR79","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1093\/ejendo\/lvaf266","volume":"194","author":"D Glintborg","year":"2026","unstructured":"Glintborg D, Ollila MM, Koskenkari N, Moller JK, Calla D, Gyllenberg F, et al. Increased prospective cardiovascular disease risk in 127 517 Nordic women with polycystic ovary syndrome: a national cohort study. Eur J Endocrinol. 2026;194(1):58\u201368. https:\/\/doi.org\/10.1093\/ejendo\/lvaf266.","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"878_CR80","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.fertnstert.2025.08.033","volume":"124","author":"I Lee","year":"2025","unstructured":"Lee I, Dokras A, Alur-Gupta S. Association of polycystic ovary syndrome with atherosclerotic cardiovascular disease events. Fertil Steril. 2025;124(5):919\u201330. https:\/\/doi.org\/10.1016\/j.fertnstert.2025.08.033.","journal-title":"Fertil Steril"},{"key":"878_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2025.112235","volume":"224","author":"H Peng","year":"2025","unstructured":"Peng H, Ren J, Zhao Y, Fang X, Wang X, Liu C, et al. Unraveling the connection between PCOS and renal complications: current insights and future directions. Diabetes Res Clin Pract. 2025;224:112235. https:\/\/doi.org\/10.1016\/j.diabres.2025.112235.","journal-title":"Diabetes Res Clin Pract"},{"key":"878_CR82","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1120119","volume":"14","author":"Y Du","year":"2023","unstructured":"Du Y, Li F, Li S, Ding L, Liu M. Causal relationship between polycystic ovary syndrome and chronic kidney disease: A Mendelian randomization study. Front Endocrinol (Lausanne). 2023;14:1120119. https:\/\/doi.org\/10.3389\/fendo.2023.1120119.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"878_CR83","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/cen.14284","volume":"93","author":"S Behboudi-Gandevani","year":"2020","unstructured":"Behboudi-Gandevani S, Amiri M, Cheraghi L, Amanollahi Soudmand S, Azizi F, Ramezani Tehrani F. The risk of chronic kidney disease among women with polycystic ovary syndrome: A long-term population-based cohort study. Clin Endocrinol. 2020;93(5):590\u20137. https:\/\/doi.org\/10.1111\/cen.14284.","journal-title":"Clin Endocrinol"},{"issue":"20","key":"878_CR84","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/cir.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Rangaswami J, Chow SL, Neeland IJ, Tuttle KR, Khan SS, et al. Cardiovascular-Kidney-Metabolic health: A Presidential Advisory From the American Heart Association. Circulation. 2023;148(20):1606\u201335. https:\/\/doi.org\/10.1161\/cir.0000000000001184.","journal-title":"Circulation"},{"key":"878_CR85","doi-asserted-by":"publisher","DOI":"10.1186\/s13293-025-00710-x","author":"AM Beltz","year":"2025","unstructured":"Beltz AM, Tronson NC, Singh M, Rezq S. Sex still matters for the brain and mental health across the lifespan. Biol Sex Differ. 2025. https:\/\/doi.org\/10.1186\/s13293-025-00710-x.","journal-title":"Biol Sex Differ"},{"issue":"10","key":"878_CR86","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41574-018-0048-7","volume":"14","author":"GJ Biessels","year":"2018","unstructured":"Biessels GJ, Despa F. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat Rev Endocrinol. 2018;14(10):591\u2013604. https:\/\/doi.org\/10.1038\/s41574-018-0048-7.","journal-title":"Nat Rev Endocrinol"},{"key":"878_CR87","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1614006","author":"S Wang","year":"2025","unstructured":"Wang S, Shi Y, Xin R, Kang H, Xiong H, Ren J. Exploring the role of insulin resistance in bridging the metabolic syndrome and Alzheimer\u2019s disease-a review of mechanistic studies. Front Endocrinol. 2025. https:\/\/doi.org\/10.3389\/fendo.2025.1614006.","journal-title":"Front Endocrinol"},{"issue":"4","key":"878_CR88","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.4525","volume":"7","author":"C Chourpiliadis","year":"2024","unstructured":"Chourpiliadis C, Zeng Y, Lovik A, Wei D, Valdimarsd\u00f3ttir U, Song H, et al. Metabolic profile and long-term risk of depression, anxiety, and stress-related disorders. JAMA Netw Open. 2024;7(4):e244525. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.4525.","journal-title":"JAMA Netw Open"},{"key":"878_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.102084","volume":"91","author":"HM Al-kuraishy","year":"2023","unstructured":"Al-kuraishy HM, Jabir MS, Albuhadily AK, Al-Gareeb AI, Rafeeq MF. The link between metabolic syndrome and Alzheimer disease: A mutual relationship and long rigorous investigation. Ageing Res Rev. 2023;91:102084. https:\/\/doi.org\/10.1016\/j.arr.2023.102084.","journal-title":"Ageing Res Rev"},{"key":"878_CR90","doi-asserted-by":"publisher","unstructured":"https:\/\/doi.org\/10.3389\/fnut.2025.1676168\/full","DOI":"10.3389\/fnut.2025.1676168\/full"},{"key":"878_CR91","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neures.2021.07.006","volume":"174","author":"S Frangou","year":"2022","unstructured":"Frangou S, Abbasi F, Watson K, Haas SS, Antoniades M, Modabbernia A, et al. Hippocampal volume reduction is associated with direct measure of insulin resistance in adults. Neurosci Res. 2022;174:19\u201324. https:\/\/doi.org\/10.1016\/j.neures.2021.07.006.","journal-title":"Neurosci Res"},{"issue":"2","key":"878_CR92","doi-asserted-by":"publisher","first-page":"300","DOI":"10.2337\/dc15-1588","volume":"39","author":"S Chatterjee","year":"2016","unstructured":"Chatterjee S, Peters SAE, Woodward M, Mejia Arango S, Batty GD, Beckett N, et al. Type 2 diabetes as a risk factor for dementia in women compared with men: a pooled analysis of 2.3\u00a0million people comprising more than 100,000 cases of dementia. Diabetes Care. 2016;39(2):300\u20137. https:\/\/doi.org\/10.2337\/dc15-1588.","journal-title":"Diabetes Care"},{"key":"878_CR93","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.885787","author":"EG Thomas","year":"2022","unstructured":"Thomas EG, Rhodius-Meester H, Exalto L, Peters SAE, van Bloemendaal L, Ponds R, et al. Sex-specific associations of diabetes with brain structure and function in a geriatric population. Front Aging Neurosci. 2022. https:\/\/doi.org\/10.3389\/fnagi.2022.885787.","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"878_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/jcm15020740","volume":"15","author":"A Szeliga","year":"2026","unstructured":"Szeliga A, Chedraui P, Meczekalski B. The impact of the menopausal transition on body composition and abdominal fat redistribution. J Clin Med. 2026;15(2):740. https:\/\/doi.org\/10.3390\/jcm15020740.","journal-title":"J Clin Med"},{"key":"878_CR95","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-023-03159-0","author":"S-L Han","year":"2023","unstructured":"Han S-L, Liu D-C, Tan C-C, Tan L, Xu W. Male- and female-specific reproductive risk factors across the lifespan for dementia or cognitive decline: a systematic review and meta-analysis. BMC Med. 2023. https:\/\/doi.org\/10.1186\/s12916-023-03159-0.","journal-title":"BMC Med"},{"issue":"12","key":"878_CR96","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1001\/jama.292.12.1431-b","volume":"292","author":"ER Rosario","year":"2004","unstructured":"Rosario ER. Age-related testosterone depletion and the development of Alzheimer disease. JAMA: The Journal of the American Medical Association. 2004;292(12):1431\u20132. https:\/\/doi.org\/10.1001\/jama.292.12.1431-b.","journal-title":"JAMA: The Journal of the American Medical Association"},{"key":"878_CR97","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-024-01316-5","author":"H Cheng","year":"2024","unstructured":"Cheng H, Zhang X, Li Y, Cao D, Luo C, Zhang Q, et al. Age-related testosterone decline: mechanisms and intervention strategies. Reprod Biol Endocrinol. 2024. https:\/\/doi.org\/10.1186\/s12958-024-01316-5.","journal-title":"Reprod Biol Endocrinol"},{"issue":"5","key":"878_CR98","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1177\/0891988720933351","volume":"34","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Kang D, Li H. Testosterone and cognitive impairment or dementia in middle-aged or aging males: causation and intervention, a systematic review and meta-analysis. J Geriatr Psychiatry Neurol. 2020;34(5):405\u201317. https:\/\/doi.org\/10.1177\/0891988720933351.","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"2","key":"878_CR99","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.59834","volume":"9","author":"Z Huang","year":"2026","unstructured":"Huang Z, Yaffe K, Li C, Xiao C, Pan Y, Sun X, et al. Chronic kidney disease severity and risk of cognitive impairment. JAMA Netw Open. 2026;9(2):e2559834. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.59834.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"878_CR100","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1038\/s41440-024-01599-6","volume":"47","author":"K Kamide","year":"2024","unstructured":"Kamide K. CKD could be a new risk factor of dementia. Hypertens Res. 2024;47(4):1090\u20131. https:\/\/doi.org\/10.1038\/s41440-024-01599-6.","journal-title":"Hypertens Res"},{"issue":"6","key":"878_CR101","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/mnh.0000000000001117","volume":"34","author":"L Merlino","year":"2025","unstructured":"Merlino L, Tollitt J, Dunne RA, Kalra PA. Pathophysiology of cognitive impairment in chronic kidney disease. Curr Opin Nephrol Hypertens. 2025;34(6):459\u201368. https:\/\/doi.org\/10.1097\/mnh.0000000000001117.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"878_CR102","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-015-0115-4","author":"T Etgen","year":"2015","unstructured":"Etgen T. Kidney disease as a determinant of cognitive decline and dementia. Alzheimers Res Ther. 2015. https:\/\/doi.org\/10.1186\/s13195-015-0115-4.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"878_CR103","doi-asserted-by":"publisher","first-page":"H137","DOI":"10.1152\/ajpheart.00617.2025","volume":"330","author":"SS Pillai","year":"2026","unstructured":"Pillai SS, Morrell CH, Rocha Dos Santos C, Lakhani HV, Goncalves BDS, Pereira DG, et al. Chronic kidney disease and cardiac remodeling potentiate cognitive impairment progression: disentangling the sex-specific cross talk of kidney-heart-brain axis. Am J Physiol Heart Circ Physiol. 2026;330(1):H137\u201356. https:\/\/doi.org\/10.1152\/ajpheart.00617.2025.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"16","key":"878_CR104","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare13161951","volume":"13","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Huang Y, Zhang W, Shi Y, Mou Y, Lan Y, et al. Depressive symptoms and associated factors among middle-aged and older patients with chronic kidney disease: gender differences based on a health ecological model. Healthcare. 2025;13(16):1951. https:\/\/doi.org\/10.3390\/healthcare13161951.","journal-title":"Healthcare"},{"key":"878_CR105","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-023-04622-1","author":"L Liu","year":"2023","unstructured":"Liu L, Yan Y, Qiu J, Chen Q, Zhang Y, Liu Y, et al. Association between sedentary behavior and depression in US adults with chronic kidney disease: NHANES 2007\u20132018. BMC Psychiatry. 2023. https:\/\/doi.org\/10.1186\/s12888-023-04622-1.","journal-title":"BMC Psychiatry"},{"issue":"1","key":"878_CR106","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1681\/asn.2018030296","volume":"30","author":"AC Ricardo","year":"2019","unstructured":"Ricardo AC, Yang W, Sha D, Appel LJ, Chen J, Krousel-Wood M, et al. Sex-related disparities in CKD progression. J Am Soc Nephrol. 2019;30(1):137\u201346. https:\/\/doi.org\/10.1681\/asn.2018030296.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"878_CR107","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1152\/japplphysiol.01095.2005","volume":"101","author":"DN Krause","year":"2006","unstructured":"Krause DN, Duckles SP, Pelligrino DA. Influence of sex steroid hormones on cerebrovascular function. J Appl Physiol. 2006;101(4):1252\u201361. https:\/\/doi.org\/10.1152\/japplphysiol.01095.2005.","journal-title":"J Appl Physiol"},{"issue":"15","key":"878_CR108","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11154405","volume":"11","author":"MY Henein","year":"2022","unstructured":"Henein MY, Vancheri S, Longo G, Vancheri F. The impact of mental stress on cardiovascular health\u2014Part II. J Clin Med. 2022;11(15):4405. https:\/\/doi.org\/10.3390\/jcm11154405.","journal-title":"J Clin Med"},{"issue":"5","key":"878_CR109","doi-asserted-by":"publisher","DOI":"10.3390\/biom11050708","volume":"11","author":"H-J Yang","year":"2021","unstructured":"Yang H-J, Koh E, Kang Y. Susceptibility of women to cardiovascular disease and the prevention potential of mind\u2013body intervention by changes in neural circuits and cardiovascular physiology. Biomolecules. 2021;11(5):708. https:\/\/doi.org\/10.3390\/biom11050708.","journal-title":"Biomolecules"},{"issue":"11","key":"878_CR110","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.jalz.2018.01.007","volume":"14","author":"FJ Wolters","year":"2018","unstructured":"Wolters FJ, Segufa RA, Darweesh SKL, Bos D, Ikram MA, Sabayan B, et al. Coronary heart disease, heart failure, and the risk of dementia: a systematic review and meta-analysis. Alzheimers Dement. 2018;14(11):1493\u2013504. https:\/\/doi.org\/10.1016\/j.jalz.2018.01.007.","journal-title":"Alzheimers Dement"},{"issue":"9","key":"878_CR111","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0184244","volume":"12","author":"SD Ginsberg","year":"2017","unstructured":"Ginsberg SD, Deckers K, Schievink SHJ, Rodriquez MMF, van Oostenbrugge RJ, van Boxtel MPJ, et al. Coronary heart disease and risk for cognitive impairment or dementia: systematic review and meta-analysis. PLoS One. 2017;12(9):e0184244. https:\/\/doi.org\/10.1371\/journal.pone.0184244.","journal-title":"PLoS One"},{"key":"878_CR112","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.117.007301","author":"LY Chen","year":"2018","unstructured":"Chen LY, Norby FL, Gottesman RF, Mosley TH, Soliman EZ, Agarwal SK, et al. Association of atrial fibrillation with cognitive decline and dementia over 20 years: the ARIC-NCS (Atherosclerosis Risk in Communities Neurocognitive Study). J Am Heart Assoc. 2018. https:\/\/doi.org\/10.1161\/jaha.117.007301.","journal-title":"J Am Heart Assoc"},{"key":"878_CR113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/367516","volume":"2012","author":"JC de la Torre","year":"2012","unstructured":"de la Torre JC. Cardiovascular risk factors promote brain hypoperfusion leading to cognitive decline and dementia. Cardiovasc Psychiatry Neurol. 2012;2012:1\u201315. https:\/\/doi.org\/10.1155\/2012\/367516.","journal-title":"Cardiovasc Psychiatry Neurol"},{"issue":"39","key":"878_CR114","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.1093\/eurheartj\/ehac061","volume":"43","author":"A Rossi","year":"2022","unstructured":"Rossi A, Mikail N, Bengs S, Haider A, Treyer V, Buechel RR, et al. Heart\u2013brain interactions in cardiac and brain diseases: why sex matters. Eur Heart J. 2022;43(39):3971\u201380. https:\/\/doi.org\/10.1093\/eurheartj\/ehac061.","journal-title":"Eur Heart J"},{"issue":"6","key":"878_CR115","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.tcm.2021.07.005","volume":"32","author":"K Liblik","year":"2022","unstructured":"Liblik K, Mulvagh SL, Hindmarch CCT, Alavi N, Johri AM. Depression and anxiety following acute myocardial infarction in women. Trends Cardiovasc Med. 2022;32(6):341\u20137. https:\/\/doi.org\/10.1016\/j.tcm.2021.07.005.","journal-title":"Trends Cardiovasc Med"},{"key":"878_CR116","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.125.044922","author":"AA Freedman","year":"2026","unstructured":"Freedman AA, Colangelo LA, Ning H, Borrowman JD, Lewis CE, Schreiner PJ, et al. Sex differences in age of onset of premature cardiovascular disease and subtypes: the Coronary Artery Risk Development in Young Adults Study. J Am Heart Assoc. 2026. https:\/\/doi.org\/10.1161\/jaha.125.044922.","journal-title":"J Am Heart Assoc"}],"container-title":["Biology of Sex Differences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13293-026-00878-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13293-026-00878-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13293-026-00878-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T22:29:26Z","timestamp":1778538566000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13293-026-00878-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":116,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["878"],"URL":"https:\/\/doi.org\/10.1186\/s13293-026-00878-w","relation":{},"ISSN":["2042-6410"],"issn-type":[{"value":"2042-6410","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"28 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"86"}}